Skip to main content
. 2023 Jan 5;14:77. doi: 10.1038/s41467-022-35727-y

Fig. 2. The mutational signatures of TP53-germline mutant childhood tumors.

Fig. 2

Top: Clinical and genomic features of the tumors (number of structural variants (SVs), presence of chromothripsis, prior platinum treatment, HRD pathway mutation). Bottom: SBS mutational signatures corresponding to COSMIC mutational signatures V3.2, scaled by mutation burden in tumor (above) and scaled to proportions of 1 for each tumor (below). X-axis depicts individual tumors. Source data are provided as a Source Data file.